Materials & Resources » Chemicals | 3-D Matrix Ltd.

3-D Matrix Ltd. | Cash Flow

Fiscal year is May-April. All values JPY Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,523,867.00
1,990,220.00
2,462,025.00
1,391,361.00
1,865,007.00
Depreciation, Depletion & Amortization
101,556.00
122,622.00
96,460.00
-
-
Other Funds
6,000.00
4,377.00
4,053.00
2,666.00
1,349.00
Funds from Operations
1,308,018.00
1,763,725.00
1,745,496.00
1,215,169.00
1,844,979.00
Changes in Working Capital
371,972.00
141,089.00
281,644.00
671,848.00
175,677.00
Net Operating Cash Flow
1,679,990.00
1,904,814.00
1,463,852.00
1,887,017.00
2,020,656.00
Capital Expenditures
39,527.00
81,610.00
138,446.00
138,462.00
92,146.00
Purchase/Sale of Investments
-
-
206,290.00
206,290.00
-
Net Investing Cash Flow
83,068.00
125,551.00
345,042.00
68,540.00
81,736.00
Issuance/Reduction of Debt, Net
12,616.00
613,456.00
14,351.00
236,007.00
-
Net Financing Cash Flow
2,359,987.00
4,510,632.00
5,104.00
256,671.00
1,503,669.00
Net Change in Cash
607,171.00
2,496,300.00
1,830,851.00
1,558,361.00
585,134.00
Free Cash Flow
1,694,708.00
1,913,445.00
1,466,263.00
1,892,984.00
2,039,062.00
Other Sources
-
-
-
713.00
10,411.00
Change in Capital Stock
2,378,603.00
5,128,465.00
23,508.00
23,331.00
1,505,019.00
Exchange Rate Effect
10,242.00
16,033.00
27,061.00
3,445.00
13,589.00
Other Uses
43,541.00
43,941.00
306.00
-
-

About 3-D Matrix

View Profile
Address
Kojimachi HF Building, 7/F
Tokyo Tokyo 102
Japan
Employees -
Website http://www.3d-matrix.co.jp
Updated 09/14/2018
3-D Matrix Ltd. engages in the research and development, manufacture, and sale of medical products. It operates through the Medical Products Development and Sale, and Research Reagent Sales divisions. The Medical Products Development and Sale division includes surgery based on own organization's peptide technology, regenerative medicine, medical equipment, and pharmaceutical research and development.